Nervonik receives regulatory approval to start First-in-Human study with Novel Peripheral Nerve Stimulation Technology for Chronic Pain

Nervonik, a medical device startup focusing on neurotechnology approaches to peripheral nerve stimulation, has received approval to conduct a first-in-human feasibility study utilizing its proprietary technology. The focus will be on chronic pain of peripheral nerve origin, although the novel technology will eventually be utilized for a variety of medical indications. Dr.